Literature DB >> 34875545

Generation of AAVS1 integrated doxycycline-inducible CRISPR-Prime Editor human induced pluripotent stem cell line.

Nike Bharucha1, Jennifer Arthur Ataam1, Alexandra A Gavidia1, Ioannis Karakikes2.   

Abstract

Prime editing uses the Cas9 nickase fused to a reverse transcriptase to copy a DNA sequence into a specific locus from a 'prime editing' guide RNA (pegRNA), eliminating the need for double-stranded DNA breaks and donor DNA templates. To facilitate prime editing in human induced pluripotent stem cells (iPSCs), we integrated a doxycycline-inducible Prime Editor protein (PE2) into the AAVS1 genomic safe harbor locus. Prime editing of iPSCs resulted in precise insertion of three nucleotides in HEK3 locus with high efficiency, demonstrating the utility of this approach. This engineered cell line can be used to edit a single or multiple genomic loci by introducing a target-specific pegRNA for precise and effective genome editing to facilitate disease modeling and functional genetics studies.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2021        PMID: 34875545      PMCID: PMC9126997          DOI: 10.1016/j.scr.2021.102610

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   1.587


  5 in total

Review 1.  Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.

Authors:  Andrew V Anzalone; Luke W Koblan; David R Liu
Journal:  Nat Biotechnol       Date:  2020-06-22       Impact factor: 54.908

2.  CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs.

Authors:  Mohammad A Mandegar; Nathaniel Huebsch; Ekaterina B Frolov; Edward Shin; Annie Truong; Michael P Olvera; Amanda H Chan; Yuichiro Miyaoka; Kristin Holmes; C Ian Spencer; Luke M Judge; David E Gordon; Tilde V Eskildsen; Jacqueline E Villalta; Max A Horlbeck; Luke A Gilbert; Nevan J Krogan; Søren P Sheikh; Jonathan S Weissman; Lei S Qi; Po-Lin So; Bruce R Conklin
Journal:  Cell Stem Cell       Date:  2016-03-10       Impact factor: 24.633

3.  Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.

Authors:  Dries A M Feyen; Isaac Perea-Gil; Renee G C Maas; Magdalena Harakalova; Alexandra A Gavidia; Jennifer Arthur Ataam; Ting-Hsuan Wu; Aryan Vink; Jiayi Pei; Nirmal Vadgama; Albert J Suurmeijer; Wouter P Te Rijdt; Michelle Vu; Prashila L Amatya; Maricela Prado; Yuan Zhang; Logan Dunkenberger; Joost P G Sluijter; Karim Sallam; Folkert W Asselbergs; Mark Mercola; Ioannis Karakikes
Journal:  Circulation       Date:  2021-04-30       Impact factor: 39.918

4.  COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites.

Authors:  Thomas J Cradick; Peng Qiu; Ciaran M Lee; Eli J Fine; Gang Bao
Journal:  Mol Ther Nucleic Acids       Date:  2014-12-02       Impact factor: 10.183

5.  Search-and-replace genome editing without double-strand breaks or donor DNA.

Authors:  Andrew V Anzalone; Peyton B Randolph; Jessie R Davis; Alexander A Sousa; Luke W Koblan; Jonathan M Levy; Peter J Chen; Christopher Wilson; Gregory A Newby; Aditya Raguram; David R Liu
Journal:  Nature       Date:  2019-10-21       Impact factor: 69.504

  5 in total
  1 in total

1.  Highly efficient generation of isogenic pluripotent stem cell models using prime editing.

Authors:  Hanqin Li; Oriol Busquets; Yogendra Verma; Khaja Mohieddin Syed; Nitzan Kutnowski; Gabriella R Pangilinan; Luke A Gilbert; Helen S Bateup; Donald C Rio; Dirk Hockemeyer; Frank Soldner
Journal:  Elife       Date:  2022-09-07       Impact factor: 8.713

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.